Glucocorticoid sensitivity and inflammatory status of peripheral blood mononuclear cells in patients with coronary artery disease

References

• Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–325.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119–1131.
   PubMed Web of Science ®Google Scholar
• de Winther MP, Kanters E, Kraal G, et al. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol. 2005;25:904–914.
   PubMed Web of Science ®Google Scholar
• Newby AC. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol. 2008;28:2108–2114.
   PubMed Web of Science ®Google Scholar
• Brunner S, Kim JO, Methe H. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease. Am J Cardiol. 2010;105:429–434.
   PubMed Web of Science ®Google Scholar
• Sternberg Z, Ghanim H, Gillotti KM, et al. Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood. Atherosclerosis. 2013;229:338–347.
   PubMed Web of Science ®Google Scholar
• Jonsson S, Lundberg AK, Jonasson L. Overexpression of MMP-9 and its inhibitors in blood mononuclear cells after myocardial infarction–is it associated with depressive symptomatology? PLoS One. 2014;9:e105572.
   PubMed Web of Science ®Google Scholar
• Bar-Or A, Nuttall RK, Duddy M, et al. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain. 2003;126:2738–2749.
   PubMed Web of Science ®Google Scholar
• Matache C, Stefanescu M, Dragomir C, et al. Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus. J Autoimmun. 2003;20:323–331.
   PubMed Web of Science ®Google Scholar
• Silverman MN, Sternberg EM. Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci. 2012;1261:55–63.
   PubMed Web of Science ®Google Scholar
• Quax RA, Manenschijn L, Koper JW, et al. Glucocorticoid sensitivity in health and disease. Nat Rev Endocrinol. 2013;9:670–686.
   PubMed Web of Science ®Google Scholar
• Lewis-Tuffin LJ, Cidlowski JA. The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann N Y Acad Sci. 2006;1069:1–9.
   PubMed Web of Science ®Google Scholar
• Harkness KA, Adamson P, Sussman JD, Davies-Jones GA, Greenwood J, Woodroofe MN. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain. 2000;123:698–709.
   PubMed Web of Science ®Google Scholar
• Russell RE, Culpitt SV, DeMatos C, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2002;26:602–609.
   PubMed Web of Science ®Google Scholar
• Park CS, Lee YS, Kwon HS, et al. Chlamydophila pneumoniae inhibits corticosteroid-induced suppression of metalloproteinase-9 and tissue inhibitor metalloproteinase-1 secretion by human peripheral blood mononuclear cells. J Med Microbiol. 2012;61:705–711.
   PubMed Web of Science ®Google Scholar
• Fantidis P, Perez De Prada T, Fernandez-Ortiz A, et al. Morning cortisol production in coronary heart disease patients. Eur J Clin Invest. 2002;32:304–308.
   PubMed Web of Science ®Google Scholar
• Nijm J, Kristenson M, Olsson AG, et al. Impaired cortisol response to acute stressors in patients with coronary disease. Implications for inflammatory activity. J Intern Med. 2007;262:375–384.
   PubMed Web of Science ®Google Scholar
• Szymanowski A, Nijm J, Kristenson M, et al. Elevated levels of circulating matrix metalloproteinase-9 are associated with a dysregulated cortisol rhythm-A case-control study of coronary artery disease. Psychoneuroendocrinology. 2011;36:139–143.
   PubMed Web of Science ®Google Scholar
• Nijm J, Jonasson L. Inflammation and cortisol response in coronary artery disease. Ann Med. 2009;41:224–233.
   PubMed Web of Science ®Google Scholar
• van den Akker EL, Koper JW, van Rossum EF, et al. Glucocorticoid receptor gene and risk of cardiovascular disease. Arch Intern Med. 2008;168:33–39.
   PubMed Web of Science ®Google Scholar
• Melo MR, Faria CD, Melo KC, et al. Real-time PCR quantitation of glucocorticoid receptor alpha isoform. BMC Mol Biol. 2004;5:19.
   PubMed Web of Science ®Google Scholar
• Bottero V, Imbert V, Frelin C, et al. Monitoring NF-kappa B transactivation potential via real-time PCR quantification of I kappa B-alpha gene expression. Mol Diagn. 2003;7:187–194.
   PubMedGoogle Scholar
• Ridker PM. Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin. Eur Heart J. 2016;37:1720–1722.
   PubMed Web of Science ®Google Scholar
• Pujols L, Xaubet A, Ramirez J, et al. Expression of glucocorticoid receptors alpha and beta in steroid sensitive and steroid insensitive interstitial lung diseases. Thorax. 2004;59:687–693.
   PubMed Web of Science ®Google Scholar
• Koga Y, Matsuzaki A, Suminoe A, et al. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children. Pediatr Blood Cancer. 2005;45:121–127.
   PubMed Web of Science ®Google Scholar
• Carvalho LA, Bergink V, Sumaski L, et al. Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Transl Psychiatry. 2014;4:e344.
   PubMed Web of Science ®Google Scholar
• Hori T, Watanabe K, Miyaoka M, et al. Expression of mRNA for glucocorticoid receptors in peripheral blood mononuclear cells of patients with Crohn’s disease. J Gastroenterol Hepatol. 2002;17:1070–1077.
   PubMed Web of Science ®Google Scholar
• Webster JC, Oakley RH, Jewell CM, et al. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci USA. 2001;98:6865–6870.
   PubMed Web of Science ®Google Scholar
• Eggert M, Kluter A, Rusch D, et al. Expression analysis of the glucocorticoid receptor and the nuclear factor-kB subunit p50 in lymphocytes from patients with rheumatoid arthritis. J Rheumatol. 2002;29:2500–2506.
   PubMed Web of Science ®Google Scholar
• Silva TS, Longui CA, Faria CD, et al. Impact of prolonged physical training on the pituitary glucocorticoid sensitivity determined by very low dose intravenous dexamethasone suppression test. Horm Metab Res. 2008;40:718–721.
   PubMed Web of Science ®Google Scholar
• Brown K, Park S, Kanno T, et al. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci USA. 1993;90:2532–2536.
   PubMed Web of Science ®Google Scholar
• Sharif O, Bolshakov VN, Raines S, et al. Transcriptional profiling of the LP0S induced NF-kappaB response in macrophages. BMC Immunol. 2007;8:1.
   PubMed Web of Science ®Google Scholar
• Torrego A, Pujols L, Roca-Ferrer J, et al. Glucocorticoid receptor isoforms alpha and beta in in vitro cytokine-induced glucocorticoid insensitivity. Am J Respir Crit Care Med. 2004;170:420–425.
   PubMed Web of Science ®Google Scholar
• Gola H, Engler A, Morath J, et al. Reduced peripheral expression of the glucocorticoid receptor alpha isoform in individuals with posttraumatic stress disorder: a cumulative effect of trauma burden. PLoS One. 2014;9:e86333.
   PubMed Web of Science ®Google Scholar
• Hamid QA, Wenzel SE, Hauk PJ, et al. Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med. 1999;159:1600–1604.
   PubMed Web of Science ®Google Scholar
• Orii F, Ashida T, Nomura M, et al. Quantitative analysis for human glucocorticoid receptor alpha/beta mRNA in IBD. Biochem Biophys Res Commun. 2002;296:1286–1294.
   PubMed Web of Science ®Google Scholar
• Kozaci DL, Chernajovsky Y, Chikanza IC. The differential expression of corticosteroid receptor isoforms in corticosteroid-resistant and -sensitive patients with rheumatoid arthritis. Rheumatology. (Oxford). 2007;46:579–585.
   PubMed Web of Science ®Google Scholar
• Goleva E, Li LB, Eves PT, et al. Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med. 2006;173:607–616.
   PubMed Web of Science ®Google Scholar
• Hausmann M, Herfarth H, Scholmerich J, et al. Glucocorticoid receptor isoform expression does not predict steroid treatment response in IBD. Gut. 2007;56:1328–1329.
   PubMed Web of Science ®Google Scholar
• Hagendorf A, Koper JW, de Jong FH, et al. Expression of the human glucocorticoid receptor splice variants alpha, beta, and P in peripheral blood mononuclear leukocytes in healthy controls and in patients with hyper- and hypocortisolism. J Clin Endocrinol Metab. 2005;90:6237–6243.
   PubMed Web of Science ®Google Scholar
• Rosewicz S, McDonald AR, Maddux BA, et al. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem. 1988;263:2581–2584.
   PubMed Web of Science ®Google Scholar
• Silva CM, Powell-Oliver FE, Jewell CM, et al. Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids. 1994;59:436–442.
   PubMed Web of Science ®Google Scholar
• Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35.
   PubMed Web of Science ®Google Scholar
• Kumari M, Shipley M, Stafford M, et al. Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II study. J Clin Endocrinol Metab. 2011;96:1478–1485.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya MR, Molloy GJ, Steptoe A. Depression is associated with flatter cortisol rhythms in patients with coronary artery disease. J Psychosom Res. 2008;65:107–113.
   PubMed Web of Science ®Google Scholar
• Waller C, Bauersachs J, Hoppmann U, et al. Blunted Cortisol Stress Response and Depression-Induced Hypocortisolism Is Related to Inflammation in Patients With CAD. J Am Coll Cardiol. 2016;67: 1124–1126.
   PubMed Web of Science ®Google Scholar
• Segerstrom SC, Boggero IA, Smith GT, et al. Variability and reliability of diurnal cortisol in younger and older adults: implications for design decisions. Psychoneuroendocrinology. 2014;49:299–309.
   PubMed Web of Science ®Google Scholar
• Bergstrom I, Lundberg AK, Jonsson S, et al. Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity. PLoS One. 2017;12:e0174177.
   PubMed Web of Science ®Google Scholar
• Takeda T, Hoshida S, Nishino M, et al. Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels. Atherosclerosis. 2003;169:155–158.
   PubMed Web of Science ®Google Scholar
• Jonsson S, Lundberg A, Kalvegren H, et al. Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris. PLoS One. 2011;6:e19340.
   PubMed Web of Science ®Google Scholar
• Hadoke PW, Iqbal J, Walker BR. Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease. Br J Pharmacol. 2009;156:689–712.
   PubMed Web of Science ®Google Scholar
• Goodwin JE, Zhang X, Rotllan N, et al. Endothelial glucocorticoid receptor suppresses atherogenesis–brief report. Arterioscler Thromb Vasc Biol. 2015;35:779–782.
   PubMed Web of Science ®Google Scholar